SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.74+0.1%Nov 28 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: B.REVERE who wrote (4217)7/10/1998 7:09:00 PM
From: Anthony Wong  Read Replies (1) of 9523
 
BR, is the report referred to by Everen Securites?

<Management reduced this figure by moving more R&D expense into this quarter's report. This accounted for about 6 cents of the 12 cent reduction.>

In any case, this seems a wise move on the part of Pfizer management. Viagra sales in Q2 is strong because of pent-up demand, but Q3 may not be as strong if new scripts levels off (though off-set in part by strong re-fill numbers). In Q4 we have European sales and hopefully Canadian sales kicking in, so that should be OK. I really have to print out the earnings report for a more detailed reading this weekend.

Anthony
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext